Sofia Ioannidou Ph.D Overview
- Firm
- Andera Partners
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
5
- Med. Deal Size
-
- Med. Valuation
-
Sofia Ioannidou Ph.D General Information
Biography
Dr. Sofia Ioannidou serves as Director at Andera Partners. She serves as Board Member at Nouscom, LogicBio Therapeutics, PegaOne, Avalyn Pharma, Exciva and TRiCares. She also serves as Member of the Supervisory Board at Tubulis. She holds a Ph.D. (Doctor of Philosophy) in Cell Biology at University College London and a Degree in Biochemistry from University of Oxford.
Contact Information
Address
- 2, place Rio de Janeiro
- 75008 Paris
- France
Sofia Ioannidou Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Andera Partners | Investor | Partner | Paris, France | PE/Buyout |
Sofia Ioannidou Ph.D Board Seats (5)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Avalyn Pharma | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Cambridge, MA | |
| Exciva | Pharmaceuticals | Privately Held (backing) | Venture Capital-Backed | Heidelberg, Germany | |
| Nouscom | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Basel, Switzerland | |
| TRiCares | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Aschheim, Germany | |
| Tubulis | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Planegg-Martinsried, Germany |
Sofia Ioannidou Ph.D Lead Partner on Deals (6)
Sofia Ioannidou Ph.D has been the lead partner on 6 deals. Their latest deal was with Nouscom, a drug discovery company. The deal was made for on 21-Mar-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Nouscom | 21-Mar-2024 | Later Stage VC (Series C) | Completed | Drug Discovery | Basel, Switzerland | |
| TRiCares | 15-Sep-2022 | Completed | Surgical Devices | Aschheim, Germany | ||
| Tubulis | 03-May-2022 | Completed | Drug Discovery | Planegg-Martinsried, Germany | ||
| Pega-One | 01-Jul-2019 | Completed | Biotechnology | France | ||
| TRiCares | 04-Jun-2018 | Later Stage VC (Series B) | Completed | Surgical Devices | Aschheim, Germany | |
| LogicBio Therapeutics | 27-Jun-2017 | Early Stage VC (Series B) | Completed | Biotechnology | Lexington, MA |
Sofia Ioannidou Ph.D Network (114)
Board Members (60)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| David Malek | Avalyn Pharma | Nan Fung Life Sciences | Cambridge, MA | |
| Jonathan Leff MD | Avalyn Pharma | Self | Cambridge, MA | |
| Nouscom | M Ventures | Basel, Switzerland | ||
| LogicBio Therapeutics | Self | Lexington, MA | ||
| Nouscom | EQT Life Sciences | Basel, Switzerland |
Portfolio Executives (48)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Stefano Colloca MD | Nouscom | Co-Founder, Chief Technical Officer & Advisor | 21-Mar-2024 | Basel, Switzerland |
| Alfredo Nicosia Ph.D | Nouscom | Co-Founder & Advisor | 21-Mar-2024 | Basel, Switzerland |
| Nouscom | Chief Financial Officer | 21-Mar-2024 | Basel, Switzerland | |
| Nouscom | Co-Founder & Advisor | 21-Mar-2024 | Basel, Switzerland | |
| Nouscom | Chief Medical Officer | 21-Mar-2024 | Basel, Switzerland |
Fund Team Members (6)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Raphael Wisniewski | Andera Partners | Edmond de Rothschild Europportunities III | Paris, France |
| Raphael Wisniewski | Edmond de Rothschild Private Equity | Edmond de Rothschild Europportunities III | Paris, France |
| Andera Partners | Paris, France | ||
| Andera Partners | Paris, France | ||
| Andera Partners | Paris, France |
Sofia Ioannidou Ph.D Affiliated Funds (2)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Edmond de Rothschild Europportunities III | Andera Partners | Growth/Expansion | Closed | 2016 | ||||
| BioDiscovery 5 | Andera Partners | Venture - General | Closed | 2018 |
Sofia Ioannidou Ph.D FAQs
-
Who is Sofia Ioannidou Ph.D?
Dr. Sofia Ioannidou serves as Director at Andera Partners.
-
How much does Sofia Ioannidou Ph.D typically invest?
Sofia Ioannidou Ph.D's median deal size is .
-
What is Sofia Ioannidou Ph.D’s main position?
Sofia Ioannidou Ph.D’s primary position is Partner.
-
What are the contact details for Sofia Ioannidou Ph.D?
Sofia Ioannidou Ph.D’s email address is s. and his phone number is +33 01 .
-
How many active board seats does Sofia Ioannidou Ph.D hold?
Sofia Ioannidou Ph.D holds 5 board seats including Avalyn Pharma, Exciva, Nouscom, TRiCares, and Tubulis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
